Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon
An Australia-based biotech company Mesoblast announced that it has began clinical trials for its stem cell therapy remestemcel-L in the treatment of COVID-19 patients experiencing Acute Respiratory Distress Syndrome (ARDS).…